The presence of a protocol-defined pulmonary exacerbation is defined by the following: One of the major criteria alone or Two of the minor signs/symptoms and fulfillment of symptom duration |
Major Criteria: (One finding alone establishes the presence of a pulmonary exacerbation)
|
(1) Absolute decrease in FEV1 (L) of ≥ 10% from best baseline at study initiation using office spirometry, unresponsive to albuterol (in participants able to reproducibly perform spirometry) |
(2)Oxygen saturation <90% on room air or absolute decrease of ≥ 5% from previous baseline |
(3) New lobar infiltrate(s) or atelectasi(e)s on chest radiograph |
(4) Hemoptysis (more than streaks on more than one occasion in past week) |
Minor Signs/Symptoms: (Two minor signs/symptoms are required with duration criteria in the absence of major criteria)
|
(1) Increased work of breathing or respiratory rate |
(2) New or increased adventitial sounds on lung exam |
(3) Weight loss ≥5% of body weight or decrease across 1 major percentile in weight percentile for age in past 6 months |
(4) Increased cough |
(5) Decreased exercise tolerance or level of activity |
(6) Increased chest congestion or change in sputum |
Sign/Symptom Duration: (Required with two minor signs/symptoms in absence of major criteria): Initial sign or symptom present for ≥ 3 days |
Duration of sign/symptoms ≥3 days |